CLTCL1 and neoplasm: The persistence of clonal mutations in ATM, PTK2, GLI3 and CLTCL1 in all tumour locations analysed in samples from diagnosis and at relapse in patient CB1002 (Fig. 2b) could indicate the relevance of these SNVs for tumour progression.